THE ASSOCIATION OF COMMUNITY CANCER CENTERS received a charitable contribution from Bristol-Myers Squibb to develop a comprehensive program in immuno-oncology for community-based providers.
The contribution will enable ACCC to establish the Institute for Clinical Immuno-Oncology to educate providers about its implementation and delivery in the community setting.
The initial phase of the program will involve the establishment of the project infrastructure, including staffing, project planning, and marketing, and identification of potential partner organizations. An advisory committee comprised of ACCC members and other IO leaders will be created to oversee the planning and development of ICLIO.
Early phases of the program will include the identification and engagement of clinician scholars and thought leaders, an educational needs assessment of the ACCC membership, a one-day national conference, a monthly series of online courses and newsletters for clinicians and fellows, and multiple scientific and policy publications highlighting the project findings and outcomes.
